Syneos Health, Inc.

Syneos Health Appoints Greg Licholai as Chief Medical Officer to Advance Next-Generation Drug Development

causaLens Expands Strategic Partnership with Syneos Health to Scale Agentic AI in Biopharma Commercialization

KAI Conversations Announces Strategic Partnership with Syneos Health to Advance U.S. Pharmaceutical Commercialization

Syneos Health Appoints Simon Bartle as Chief Human Resources Officer

Real World Evidence (RWE) Oncology Market to Reach $3.51 Billion by 2035, Growing at a CAGR of 14.7% from 2025--Exclusive Report by Meticulous Research®

SCIENTURE Announces Commercial Operations Leadership and Strategic Agreement with Syneos Health, a leading Contract Sales Organization

Syneos Health Appoints Costa Panagos as Chief Executive Officer

Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE®

Elligo Health Research Announces Expansion of Study Marketplace With Syneos Health

Syneos Health Closes Transaction with Private Investment Firms

Civitas Resources Set to Join S&P MidCap 400; Hayward Holdings to Join S&P SmallCap 600

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Syneos Health, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 25, 2023 - (NASDAQ: SYNH)

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Syneos Health, Inc. with Losses of $100,000 to Contact the Firm

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Syneos Health, Inc. with Losses of $100,000 to Contact the Firm

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Syneos Health, Inc. (SYNH)

Attention SYNH Shareholders: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed against Syneos Health, Inc. (SYNH) and Encourages Investors to Contact the Firm

SYNH Investors Have Opportunity to Lead Syneos Health, Inc. Securities Fraud Lawsuit

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syneos Health, Inc. - SYNH

FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Syneos Health, Inc. with Losses of $100,000 to Contact the Firm

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Syneos Health, Inc.(SYNH) Investors of a Class Action Lawsuit and Upcoming Deadline